课题基金 / 基金详情

Bacterial pathogenesis: dissecting the early stages of cellular invasion by the obligate intracellular bacterium Orientia tsutsugamushi

Bacterial pathogenesis: dissecting the early stages of cellular invasion by the obligate intracellular bacterium Orientia tsutsugamushi
细菌发病机制:剖析专性细胞内细菌恙虫病东方体入侵细胞的早期阶段
批准号:
MR/N012380/1
负责人:
Jeanne Salje
金额:
$25.54万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
恙虫病是东南亚许多农村地区因高烧住院的主要原因之一。这种疾病是由患者被一种叫做螨虫的小型叮咬节肢动物咬伤引起的,这种节肢动物传播一种叫做恙虫病东方体的危险细菌。感染这种细菌会引起一系列症状,包括高烧、皮疹和肌肉疼痛。如果感染没有得到迅速和正确的治疗,可能会导致多器官衰竭和死亡。据估计,每年有10亿人面临风险,100万人感染这种疾病。由于症状类似于许多其他热带传染病-如登革热和其他细菌或病毒感染-患者往往被误诊,因此没有得到适当的治疗。这对个体患者来说有严重并发症的风险,并且由于滥用抗生素治疗,这也导致抗生素耐药性问题日益严重。由于这种疾病的高发病率和严重性,我们必须详细研究导致这种疾病的细菌,这将有助于我们在未来开发更好的诊断,疫苗和治疗方法。为了充分了解传染病,从而改善患者护理,有必要了解导致这种疾病的生物体的基本生物学。特别重要的是,要确切地了解这种生物体是如何在人体内生长的,以及为什么它会使这些人生病。人类体内一直有大约100万亿个细菌在生长,其中绝大多数不会造成不良影响,实际上是有益的。“致病性”的研究探讨了少数细菌如何以及为什么会引起人类疾病。在O.引起恙虫病的恙虫病细菌,其致病性的第一步是进入人体细胞内部。大多数细菌可以在人体细胞内存活,也可以在环境中自由存活:O。恙虫病则不能。O.恙虫病只有在身体位于另一个细胞内时才能存活和复制。因此,我们越能了解这种细菌如何进入人体细胞,然后避免被它们杀死,我们就越能探索阻止这一重要过程的方法,从而消除患者体内的细菌。恙虫病进入人体细胞以及进入后24小时内的情况。人类细胞已经发展出了复杂的策略来消除进入它们内部的大多数细菌,但是O。恙虫病已经学会了如何避免这些。我们想知道它是如何做到这一点的。我们将使用高通量筛选方法来研究这些发病机制的早期事件。这意味着我们将系统地研究人类基因组中的所有基因,试图找到细菌为了进入细胞并在那里生存而劫持的基因。一旦我们确定了这些重要的人类基因,我们将做更多的实验来了解细菌如何利用它们进入人体细胞并在人体细胞内生存的细节。这项研究的结果将是更详细地了解细菌O。恙虫病进入人体细胞,以及它如何避免被人体细胞杀死。这将有助于我们制定新的战略,在未来阻止这些过程。
英文摘要
Scrub typhus is one of the leading causes of hospitalisation from high fever in many rural parts of Southeast Asia. The disease is caused when a patient is bitten by a small biting arthropod called a mite, which transmits a dangerous bacterium called Orientia tsutsugamushi. Infection with this bacterium causes a range of symptoms that include high fever, rash and muscle pain. If the infection is not treated quickly and correctly it can result in multiple organ failure and death. It is estimated that 1 billion people are at risk and 1 million people are infected with this disease every year. Because the symptoms are similar to many other tropical infectious diseases - such as dengue fever and other bacterial or viral infections - patients are often misdiagnosed and therefore not treated properly. This risks severe complications for the individual patient and it also contributes to the growing problem of antibiotic resistance due to misuse of antibiotic treatments. Given the high incidence and severity of this disease, it is very important that we study the bacteria that causes it in detail as this will help us to develop better diagnostics, vaccines, and treatments in the future.In order to understand fully an infectious disease, and therefore improve patient care, it is necessary to understand the basic biology of the organism that causes the disease. In particular, it is important to understand exactly how that organism grows inside humans, and why it makes those humans sick. Humans have around 100 trillion bacteria growing on and inside them all the time, and the vast majority of them cause no ill effects and are actually beneficial. The study of 'pathogenicity' explores how and why a small minority of bacteria cause disease in humans. In the case of O. tsutsugamushi, the bacteria that causes scrub typhus, the first step in its pathogenicity is its entry to the inside of human cells. Most bacteria can survive either inside human cells or free in the environment: O. tsutsugamushi cannot. O. tsutsugamushi can only survive and replicate when it is physically located inside another cell. Therefore the more we can understand about how this bacteria gains initial access into human cells, and then avoids being killed by them, the more we can explore ways to block this essential process and therefore eliminate the bacteria from the patient.In this study we will explore the detailed mechanisms by which O. tsutsugamushi gets into humans cells and what it does in the first 24 hours after entry. Human cells have developed sophisticated strategies to eliminate most bacteria that get inside them, but O. tsutsugamushi has learned how to avoid these. We want to understand exactly how it does this. We will use a high-throughput screening approach to study these early events of pathogenesis. This means that we will systematically look at all the genes in the human genome to try and find the ones that the bacteria hijacks in order to get into the cells and survive there. Once we have identified these important human genes we will do more experiments to understand the details of exactly how the bacteria uses them in order to gain entry and then survive within the human cells. The outcome of this study will be a more detailed understanding of exactly how the bacterium O. tsutsugamushi gets into human cells, and how it avoids being killed by them. This will help us develop new strategies to block these processes in the future.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41467-022-31176-9
发表时间: 2022-06-23
期刊: Nature communications
影响因子: 16.6
作者: []
通讯作者:
Clickable methionine as a universal probe for labelling intracellular bacteria
可点击的蛋氨酸作为标记细胞内细菌的通用探针
DOI: 10.1101/784371
发表时间: 2019
期刊:
影响因子: --
作者: [Atwal S]
通讯作者: Atwal S
DOI: 10.1371/journal.pntd.0006566
发表时间: 2018-06
期刊: PLoS neglected tropical diseases
影响因子: 3.8
作者: [Batty EM, Chaemchuen S, Blacksell S, Richards AL, Paris D, Bowden R, Chan C, Lachumanan R, Day N, Donnelly P, Chen S, Salje J]
通讯作者: Salje J
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
  • 批准号:
    82371454
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    郝勇
  • 依托单位:
cGAS-STING通路调控单核细胞活化参与Graves病发病的机制研究
  • 批准号:
    82370787
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王曙
  • 依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
  • 批准号:
    82370743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姜娜
  • 依托单位: